Sentence examples for rejection table from inspiring English sources

Studies rejected at this stage were recorded in a rejection table with reasons for rejection.

(Table 2, 3) When we examined 57 acute cellular rejection pathologic findings according to donor SDF1 rs1801157 genetic variations (GG, n = 43; GA, n = 13; AA, n = 1), there were no significant differences between the polymorphism and severity of acute rejection (Table S1).

Among the 27 pegloticase-naïve patients, 7 were organ transplant recipients, who were receiving various immunosuppressive regimens to prevent graft rejection (Table  2).

Growth of human (xenogeneic) tumour cells can be achieved using immunodeficient (e.g., nude or SCID) mice to prevent rejection (Table 1A).

Several genes in the list of up-regulated genes after allogeneic transplantation might serve as novel markers for acute rejection (Table 5).

Donor age (R=−0.46; p<0.001) and recipient age (R=−0.46; p<0.001) negatively correlated with eCrcl at 1 year post-transplant, while there was no correlation of renal function with donor and recipient gender, type of donation (deceased vs living), HLA MM, average CNI concentration, steroid-free regimen of immunosuppression or history of acute rejection (table 3).

In 42% of total interactions (80% of rejections; Table 1), incompatible interactions started with the formation of a borderline.

For the 600 700-ms and 700–800-ms intervals, negative repetition effects were reliable at all electrode clusters for target hits and related lure correct rejections (Table 3; all pairwise p values < 0.01).

The implication of inappropriate patches taking longer to be submitted is that the overhead they cause is higher than what the rejection rate (Table 1) suggests.

In 5% (of all interactions) or in 14% (of initially-observed fusions) of cases, the initial state of tissue fusion developed into transitory fusion [ 6, 36], and revealed rejection reactions (Table 1).

They have the potential to treat leukemia and various other blood cancers (AS1), non-Hodgkin's lymphoma (AS2), pancreatic cancer (AS3), inflammatory bowel disease, pouchitis, asthma (AS4), glioblastoma (AS5), and corneal graft rejection (AS6) (Table  1).